Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × SCLC,Extensive Stage × niraparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 10 Prostatic Neoplasms 3 Breast Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 2 Neoplasms 2 Neoplasm Metastasis 2 Fallopian Tube Neoplasms 2 Brain Neoplasms 2 Advanced Solid Tumor 2 Triple Negative Breast Neoplasms 1 SCLC,Extensive Stage 1 Rare Tumor 1 Penile Neoplasms 1 Pathologic Complete Response 1 Pancreatic Adenocarcinoma Metastatic 1 Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma 1 Ovarian Carcinosarcoma 1 Oropharyngeal Neoplasms 1 Mouth Neoplasms 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Laryngeal Diseases 1 Hemangiosarcoma 1 Glioblastoma 1 Carcinoma, Squamous Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma 1 Biliary Tract Neoplasms 1

Interventions

Etoposide 2 pembrolizumab 1 olaparib 1 niraparib 1 atezolizumab 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05718323 2026-02-06

RAISE

ETOP IBCSG Partners Foundation

Phase 2 Recruiting

SCLC,Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡